The aggregation of a dipeptide, L-leucine-glycine (Leu−Gly), at 100 mmol dm −3 has been observed in 1,1,1,3,3,3-hexafluoroisopropanol (HFIP)−water and 2-propanol (2-PrOH)−water solvents at various alcohol mole fractions, x A , using the dynamic light scattering technique and molecular dynamics (MD) simulations. Leu−Gly was dissolved into the HFIP solvents at the concentration over the entire x A range, while the dipeptide was not dissolved in the 2-PrOH solvents above x A = 0.6. Interestingly, the MD snapshots showed different shapes of Leu−Gly aggregates in the HFIP and 2-PrOH solvents. A linear-shaped aggregate forms in the former; in contrast, a spherical-shaped aggregate is generated in the latter. The solvation structure of each moiety of Leu−Gly in the HFIP and 2-PrOH solvents was observed using experimental and theoretical techniques, 1 H and 13 C NMR, IR, and 19 F− 1 H HOESY measurements and MD simulations. These results gave us the reasons for the different shapes of Leu−Gly aggregates in both solvents. In the HFIP solvents, most of the moieties of the dipeptide are easily solvated by HFIP. This induces the elongated structure of Leu−Gly, leading to the electrostatic interaction between the N-(NH 3 + group) and C-(COO − group) terminals of dipeptide molecules. On the other hand, in the 2-PrOH solvents, water molecules that initially solvate the moieties of Leu−Gly, such as the N-and C-terminals and the peptide linkage, are not easily eliminated even as the x A is close to 0.6. The water molecules can bridge such moieties of Leu−Gly to form spherical-shaped aggregates. The diffusion coefficients of Leu−Gly in both alcohol−water binary solvents were experimentally determined by NMR DOSY to estimate the geometries of the aggregates in the solvents. The sizes of Leu−Gly aggregates obtained by DOSY for both solvent systems were consistent with those estimated from the MD snapshots.